Novo Nordisk launches Wegovy in India, targets obesity treatment...

Dununu.com Dununu

Sponsored

Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection

RSS Feed Business

Posted

48

Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug targets India's large obese population. The company aims to create awareness and collaborate with stakeholders to combat obesity, citing its significant impact on India's GDP.

Read Full Article

Please log in to like, share and comment!

NYC Mayoral polls: Democrat Zohran Mamdani wins primary, progressive economic ideas trump Cuomo; what's next?

In a stunning upset, Zohran Mamdani, a progressive state assemblyman, has emerged as the...

By 0 2

Protesters say Bezos' star-studded Venice wedding highlights growing inequality

By 0 1

Revolutionary war-era boat being painstakingly rebuilt after centuries buried beneath Manhattan

A revolutionary war-era gunboat, discovered at the World Trade Center site in 2010, is being...

By 0 1

JLR to start assembling luxury cars in TN by 2026; Rs 9k cr investment planned

Jaguar Land Rover (JLR), owned by Tata Motors, will begin assembling Range Rover Evoque and Velar...

By 0 4

'Think twice...': Ravi Shastri fires warning to Gautam Gambhir, Shubman Gill & Co on Jasprit Bumrah

Ravi Shastri suggests India may need to reconsider resting Jasprit Bumrah if they fall 2-0 behind...

By 0 5